GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...
Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...
The companies didn’t provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide ...
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
Most Americans have never thought much about hepatitis B, and that’s precisely because the vaccine works so well.
The American Association for the Study of Liver Diseases and Infectious Diseases Society of America have updated guidance on ...
In hepatitis B virus (HBV) infection, the capacity to mount a functional virus-specific T-cell response has long been considered the principal, if not the sole, immunological determinant of viral ...
This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
Researchers have reconstructed ancient herpesvirus genomes from Iron Age and medieval Europeans, revealing that HHV-6 has ...
The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback